Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-059374
Filing Date
2018-02-27
Accepted
2018-02-27 07:22:57
Documents
80
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d522898d10k.htm 10-K 1157742
2 EX-21.1 d522898dex211.htm EX-21.1 1840
3 EX-23.1 d522898dex231.htm EX-23.1 1793
4 EX-31.1 d522898dex311.htm EX-31.1 6800
5 EX-31.2 d522898dex312.htm EX-31.2 6787
6 EX-32.1 d522898dex321.htm EX-32.1 4184
7 EX-32.2 d522898dex322.htm EX-32.2 4171
14 GRAPHIC g522898g13y62.jpg GRAPHIC 89885
  Complete submission text file 0001193125-18-059374.txt   5424170

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srra-20171231.xml EX-101.INS 867555
9 XBRL TAXONOMY EXTENSION SCHEMA srra-20171231.xsd EX-101.SCH 59558
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20171231_cal.xml EX-101.CAL 76800
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20171231_def.xml EX-101.DEF 230105
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20171231_lab.xml EX-101.LAB 500976
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20171231_pre.xml EX-101.PRE 358555
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37490 | Film No.: 18642922
SIC: 2834 Pharmaceutical Preparations